BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11472348)

  • 1. Safety and efficacy of thalidomide in patients with myelofibrosis with myeloid metaplasia.
    Barosi G; Grossi A; Comotti B; Musto P; Gamba G; Marchetti M
    Br J Haematol; 2001 Jul; 114(1):78-83. PubMed ID: 11472348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide in myelofibrosis with myeloid metaplasia: a pooled-analysis of individual patient data from five studies.
    Barosi G; Elliott M; Canepa L; Ballerini F; Piccaluga PP; Visani G; Marchetti M; Pozzato G; Zorat F; Tefferi A
    Leuk Lymphoma; 2002 Dec; 43(12):2301-7. PubMed ID: 12613516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide treatment in myelofibrosis with myeloid metaplasia.
    Elliott MA; Mesa RA; Li CY; Hook CC; Ansell SM; Levitt RM; Geyer SM; Tefferi A
    Br J Haematol; 2002 May; 117(2):288-96. PubMed ID: 11972510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide therapy for myelofibrosis with myeloid metaplasia.
    Thomas DA; Giles FJ; Albitar M; Cortes JE; Verstovsek S; Faderl S; O'Brien SM; Garcia-Manero G; Keating MJ; Pierce S; Zeldis J; Kantarjian HM
    Cancer; 2006 May; 106(9):1974-84. PubMed ID: 16583431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in agnogenic and secondary myelofibrosis.
    Canepa L; Ballerini F; Varaldo R; Quintino S; Reni L; Clavio M; Miglino M; Pierri I; Gobbi M
    Br J Haematol; 2001 Nov; 115(2):313-5. PubMed ID: 11703326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
    Marchetti M; Barosi G; Balestri F; Viarengo G; Gentili S; Barulli S; Demory JL; Ilariucci F; Volpe A; Bordessoule D; Grossi A; Le Bousse-Kerdiles MC; Caenazzo A; Pecci A; Falcone A; Broccia G; Bendotti C; Bauduer F; Buccisano F; Dupriez B
    J Clin Oncol; 2004 Feb; 22(3):424-31. PubMed ID: 14752066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durable responses to thalidomide-based drug therapy for myelofibrosis with myeloid metaplasia.
    Mesa RA; Elliott MA; Schroeder G; Tefferi A
    Mayo Clin Proc; 2004 Jul; 79(7):883-9. PubMed ID: 15244384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.
    Piccaluga PP; Visani G; Pileri SA; Ascani S; Grafone T; Isidori A; Malagola M; Finelli C; Martinelli G; Ricci P; Baccarani M; Tura S
    Leukemia; 2002 Sep; 16(9):1609-14. PubMed ID: 12200671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
    Arora B; Mesa R; Tefferi A
    Leuk Lymphoma; 2004 Dec; 45(12):2373-86. PubMed ID: 15621750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide for the treatment of idiopathic myelofibrosis.
    Strupp C; Germing U; Scherer A; Kündgen A; Mödder U; Gattermann N; Haas R
    Eur J Haematol; 2004 Jan; 72(1):52-7. PubMed ID: 14962263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
    Abgrall JF; Guibaud I; Bastie JN; Flesch M; Rossi JF; Lacotte-Thierry L; Boyer F; Casassus P; Slama B; Berthou C; Rodon P; Leporrier M; Villemagne B; Himberlin C; Ghomari K; Larosa F; Rollot F; Dugay J; Allard C; Maigre M; Isnard F; Zerbib R; Cauvin JM;
    Haematologica; 2006 Aug; 91(8):1027-32. PubMed ID: 16885042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negligible clinical effects of thalidomide in patients with myelofibrosis with myeloid metaplasia.
    Merup M; Kutti J; Birgergård G; Mauritzson N; Björkholm M; Markevärn B; Maim C; Westin J; Palmblad J;
    Med Oncol; 2002; 19(2):79-86. PubMed ID: 12180484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia.
    Mesa RA; Steensma DP; Pardanani A; Li CY; Elliott M; Kaufmann SH; Wiseman G; Gray LA; Schroeder G; Reeder T; Zeldis JB; Tefferi A
    Blood; 2003 Apr; 101(7):2534-41. PubMed ID: 12517815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lenalidomide therapy in myelofibrosis with myeloid metaplasia.
    Tefferi A; Cortes J; Verstovsek S; Mesa RA; Thomas D; Lasho TL; Hogan WJ; Litzow MR; Allred JB; Jones D; Byrne C; Zeldis JB; Ketterling RP; McClure RF; Giles F; Kantarjian HM
    Blood; 2006 Aug; 108(4):1158-64. PubMed ID: 16609064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly.
    Berrebi A; Feldberg E; Spivak I; Shvidel L
    Haematologica; 2007 Feb; 92(2):e15-6. PubMed ID: 17405746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Advances in thalidomide therapy for idiopathic myelofibrosis].
    Song L; Chen JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):651-3. PubMed ID: 19968089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
    Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia.
    Tefferi A; Elliot MA
    Blood; 2000 Dec; 96(12):4007. PubMed ID: 11186278
    [No Abstract]   [Full Text] [Related]  

  • 19. Improvement of Anaemia in Patients with Primary Myelofibrosis by Low-Dose Thalidomide and Prednisone.
    Bělohlávková P; Maisnar V; Voglová J; Buchler T; Žák P
    Acta Medica (Hradec Kralove); 2016; 59(2):50-3. PubMed ID: 27526305
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thalidomide treatment in a myelofibrosis patient with leukemia transformation.
    Huang WH; Li MS; Chu SC; Wang TF; Kao RH; Wu YF
    Int J Hematol; 2014 Feb; 99(2):188-92. PubMed ID: 24307514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.